Murray: Senate Counterpart To Cures Bill Must Hike Funding For NIH, FDA To Get Her Support

October 7, 2015 at 10:22 AM
Senate health committee ranking Democrat Patty Murray (WA) said her support for a yet-to-be introduced Senate counterpart to the House Cures bill hinges on the measure increasing funds for the National Institutes of Health and FDA, issuing the warning in prepared remarks at a Senate Appropriations subcommittee on Labor/HHS hearing Wednesday (Oct.7). Lobbyist sources have told Inside Health Policy that the Senate health committee is weighing a funding increase for NIH in its upcoming companion bill to the House-passed...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.